{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137045443501568.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1172/jci116299"}},{"identifier":{"@type":"URI","@value":"http://www.jci.org/articles/view/116299/files/pdf"}}],"dc:title":[{"@value":"A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus."}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380861707115281550","@type":"Researcher","foaf:name":[{"@value":"I Z Zador"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045443501568","@type":"Researcher","foaf:name":[{"@value":"G D Deshmukh"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045443501571","@type":"Researcher","foaf:name":[{"@value":"R Kunkel"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045443501573","@type":"Researcher","foaf:name":[{"@value":"K Johnson"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045443501569","@type":"Researcher","foaf:name":[{"@value":"N S Radin"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045443501570","@type":"Researcher","foaf:name":[{"@value":"J A Shayman"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00219738"}],"prism:publicationName":[{"@value":"Journal of Clinical Investigation"}],"dc:publisher":[{"@value":"American Society for Clinical Investigation"}],"prism:publicationDate":"1993-03-01","prism:volume":"91","prism:number":"3","prism:startingPage":"797","prism:endingPage":"803"},"reviewed":"false","url":[{"@id":"http://www.jci.org/articles/view/116299/files/pdf"}],"createdAt":"2008-02-29","modifiedAt":"2023-08-03","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360021390749854336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Enhanced Levels of Glycosphingolipid GM3 Delay the Progression of Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659521520384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Globo-series glycosphingolipids enhance Toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593808407552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sphingolipids and Kidney Disease: Possible Role of Preeclampsia and Intrauterine Growth Restriction (IUGR)"}]},{"@id":"https://cir.nii.ac.jp/crid/2050307417131910784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1172/jci116299"},{"@type":"CROSSREF","@value":"10.3390/ijms241411355_references_DOI_8ciw9QY00mqgNWslp0WtUpN9Pge"},{"@type":"CROSSREF","@value":"10.1093/glycob/cwy105_references_DOI_8ciw9QY00mqgNWslp0WtUpN9Pge"},{"@type":"CROSSREF","@value":"10.34067/kid.0006322020_references_DOI_8ciw9QY00mqgNWslp0WtUpN9Pge"},{"@type":"CROSSREF","@value":"10.1007/s10157-022-02249-2_references_DOI_8ciw9QY00mqgNWslp0WtUpN9Pge"}]}